IRON Disc Medicine Inc

Price (delayed)

$79.65

Market cap

$3.06B

P/E Ratio

N/A

Dividend/share

N/A

EPS

-$6.58

Enterprise value

$3.02B

?
Relative Growth: Rel. Growth: 3
Relative Strength: Rel. Strength: 54
Relative Valuation: Rel. Valuation: N/A
Relative Profitability: Rel. Profitability: 4

. Disc Medicine is a clinical-stage biopharmaceutical company committed to discovering, developing, and commercializing novel treatments for patients who suffer from serious hematologic diseases. We are building a portfolio of ...

Highlights
IRON's equity is down by 6% since the previous quarter but it is up by 4.9% year-on-year
The company's debt has surged by 97% YoY and by 96% QoQ
Disc Medicine's net income has shrunk by 69% YoY

Key stats

What are the main financial stats of IRON

IRON stock price

How has the Disc Medicine stock price performed over time
Intraday
0.94%
1 week
0.56%
1 month
3.43%
1 year
35%
YTD
0.3%
QTD
8.9%

Financial performance

How have Disc Medicine's revenue and profit performed over time
Revenue
$0
Gross profit
$0
Operating income
-$269.27M
Net income
-$245.89M
Gross margin
N/A
Net margin
N/A
Disc Medicine's net income has shrunk by 69% YoY
The operating income has dropped by 60% year-on-year

Price vs fundamentals

How does IRON's price correlate with its fundamentals

Growth

What is Disc Medicine's growth rate over time

Valuation

What is Disc Medicine stock price valuation
P/E
N/A
P/B
4.72
P/S
N/A
EV/EBIT
N/A
EV/EBITDA
N/A
EV/Sales
N/A
IRON's EPS is down by 47% YoY
IRON's price to book (P/B) is 73% higher than its 5-year quarterly average of 2.7 and 17% higher than its last 4 quarters average of 4.0
IRON's equity is down by 6% since the previous quarter but it is up by 4.9% year-on-year

Efficiency

How efficient is Disc Medicine business performance
The ROE fell by 40% YoY
Disc Medicine's return on assets has decreased by 37% YoY
Disc Medicine's ROIC has decreased by 16% YoY but it has increased by 3% from the previous quarter

Dividends

What is IRON's dividend
DPS
N/A
Dividend yield
N/A
Payout ratio
N/A

There are no recent dividends present for IRON.

Financial health

How did Disc Medicine financials performed over time
IRON's total liabilities has surged by 79% year-on-year and by 47% since the previous quarter
Disc Medicine's quick ratio has decreased by 25% YoY
The company's debt is 91% lower than its equity
The company's debt has surged by 97% YoY and by 96% QoQ
IRON's debt to equity has soared by 80% QoQ and by 80% YoY

All financial data is based on trailing twelve months (TTM) periods - updated quarterly, unless otherwise specified.